Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Antineutrophil cytoplasmic antibodies in systemic sclerosis.

× No keyword cloud information.

8 in total

Review 1. Systemic sclerosis.

Authors: M I Perez; S R Kohn
Journal: J Am Acad Dermatol Date: 1993-04 Impact factor: 11.527

Review 2. Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential.

Authors: C G Kallenberg; E Brouwer; J J Weening; J W Tervaert
Journal: Kidney Int Date: 1994-07 Impact factor: 10.612

3. Autoantibodies against neutrophil cytoplasm components in systemic lupus erythematosus and in hydralazine-induced lupus.

Authors: L Nässberger; A G Sjöholm; H Jonsson; G Sturfelt; A Akesson
Journal: Clin Exp Immunol Date: 1990-09 Impact factor: 4.330

4. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

Authors:
Journal: Arthritis Rheum Date: 1980-05

5. Antineutrophil cytoplasmic autoantibody-associated diseases: a rheumatologist's perspective.

Authors: W L Gross; W H Schmitt; E Csernok
Journal: Am J Kidney Dis Date: 1991-08 Impact factor: 8.860

6. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis.

Authors: F J van der Woude; N Rasmussen; S Lobatto; A Wiik; H Permin; L A van Es; M van der Giessen; G K van der Hem; T H The
Journal: Lancet Date: 1985-02-23 Impact factor: 79.321

7. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis.

Authors: R J Falk; J C Jennette
Journal: N Engl J Med Date: 1988-06-23 Impact factor: 91.245

8. Antineutrophil cytoplasmic autoantibodies in 6 patients with renal failure and systemic sclerosis.

Authors: H Endo; T Hosono; H Kondo
Journal: J Rheumatol Date: 1994-05 Impact factor: 4.666

8 in total

4 in total

Antineutrophil cytoplasmic antibodies in systemic sclerosis.

Review 1. Systemic sclerosis.

Review 2. Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential.

3. Autoantibodies against neutrophil cytoplasm components in systemic lupus erythematosus and in hydralazine-induced lupus.

4. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

5. Antineutrophil cytoplasmic autoantibody-associated diseases: a rheumatologist's perspective.

6. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis.

7. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis.

8. Antineutrophil cytoplasmic autoantibodies in 6 patients with renal failure and systemic sclerosis.

1. Scleroderma associated with ANCA-associated vasculitis.

Review 2. Scleroderma associated with ANCA-associated vasculitis.

3. Microscopic polyangiitis in systemic sclerosis.

4. Raynaud's phenomenon and digital ischemia: a practical approach to risk stratification, diagnosis and management.